Vitenskapelig artikkel

• Gandhar K. Datar; Elmira Khabusheva; Archish Anand et al. (2025). Disparate leukemia mutations converge on nuclear phase-separated condensates. (ekstern lenke)
• Brunangelo Falini; Bjørn Tore Gjertsen; Vibeke Andresen (2023). The acidic stretch and the C-terminal nuclear export signal motif of NPM1 mutant: are they druggable in AML?. (ekstern lenke)
• Giulia Pianigiani; Francesca Rocchio; Sara Peruzzi et al. (2022). The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein. (ekstern lenke)
• Benedicte Sjo Tislevoll; Monica Hellesøy; Oda Helen Eck Fagerholt et al. (2022). Early response evaluation by single cell signaling profiling in acute myeloid leukemia. (ekstern lenke)
• Daniele Mercatelli; Massimo Bortolotti; Vibeke Andresen et al. (2020). Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling. (ekstern lenke)
• Clemens Furnes; Vibeke Andresen; Anne Marie Szilvay (2008). Functional rescue of an oligomerization-defective HIV-1 Rev mutant by fusion with an oligomeric tag. (ekstern lenke)
• Calum Leitch; Tereza Osdal; Vibeke Andresen et al. (2016). Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia. (ekstern lenke)
• Vibeke Andresen; Bjarte Skoe Erikstein; Herschel Mukherjee et al. (2016). Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. (ekstern lenke)
• Alessandra Venanzi; Valeria Cardinali; Vincenzo Perriello et al. (2024). Starry sky pattern predicts RAS pathway activation in NPM1-mutated acute myeloid leukemia. (ekstern lenke)
• Maria Omsland; Cynthia A. Pise-Masison; Dai Fujikawa et al. (2018). Inhibition of tunneling nanotube (TNT) formation and Human T-cell leukemia virus type 1 (HTLV-1) transmission by cytarabine. (ekstern lenke)
• Trung Quang Ha; Vibeke Andresen; Bjarte Skoe Erikstein et al. (2024). Preclinical activity of resazurin in acute myeloid leukaemia. (ekstern lenke)
• Francesca Rende; Ilaria Cavallari; Vibeke Andresen et al. (2015). Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms. (ekstern lenke)
• Maria Omsland; Øystein Bruserud; Bjørn Tore Gjertsen et al. (2017). Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-KB inhibition in acute myeloid leukemia (AML). (ekstern lenke)
• Maria Fernanda De Castro-Amarante; Cynthia A. Pise-Masison; Katherine McKinnon et al. (2016). Human T cell leukemia virus type 1 infection of the three monocyte subsets contributes to viral burden in humans. (ekstern lenke)
• Elisabeth Silden; Sigrun Margrethe Hjelle; Line Wergeland et al. (2013). Expression of TP53 isoforms p53 beta or p53 gamma enhances chemosensitivity in TP53(null) cell lines. (ekstern lenke)
• Jad Othman; Manja Meggendorfer; Enrico Tiacci et al. (2023). Overlapping features of therapy-related and de novo NPM1-mutated AML. (ekstern lenke)
• Maria Omsland; Vibeke Andresen; Stein-Erik Gullaksen et al. (2020). Tyrosine kinase inhibitors and interferon‐α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines (. (ekstern lenke)
• Herschel Mukherjee; Kok-Ping Chan; Vibeke Andresen et al. (2015). Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 mediate the cellular localization of nucleophosmin and its aml-associated mutants. (ekstern lenke)
• Benedicte Sjo Tislevoll; Monica Hellesøy; Oda Helen Eck Fagerholt et al. (2023). Early response evaluation by single cell signaling profiling in acute myeloid leukemia. (ekstern lenke)
• Alesia A. Khan; Daniel James; Vibeke Andresen et al. (2024). Pre-B acute lymphoblastic leukemia presenting with NPM1 and FLT3 mutations. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Vibeke Andresen; Bjørn Tore Gjertsen (2017). Drug Repurposing for the Treatment of Acute Myeloid Leukemia. (ekstern lenke)
• Vibeke Andresen; Bjørn Tore Gjertsen (2019). Clinical trials of repurposing medicines in acute myeloid leukemia: Limitations and possibilities in the age of precision therapy. (ekstern lenke)
• Vibeke Andresen; Maria Omsland (2013). "Tunneling nanotube" nyoppdaget budbringer mellom celler. (ekstern lenke)

Leserbrev

• Vibeke Andresen; Xiang Wang; Sakhila Ghimire et al. (2013). Tunneling nanotube (TNT) formation is independent of p53 expression. (ekstern lenke)
• Brunangelo Falini; Maria Paola Martelli; Lorenzo Brunetti et al. (2023). The NPM1 mutant defines AML irrespective of blast count. (ekstern lenke)

Doktorgradsavhandling

• Maria Omsland; Vibeke Andresen (2017). Investigation of the intercellular structure tunneling nanotube (TNT) in leukemia. (ekstern lenke)

Konferanseposter

• Vibeke Andresen; Maria Omsland; Bjørn Tore Gjertsen et al. (2014). Cell-to-Cell Communication in Acute Myeloid Leukemia by Tunneling Nanotubes. (ekstern lenke)

Rettelse i tidsskrift

• Benedicte Sjo Tislevoll; Monica Hellesøy; Oda Helen Eck Fagerholt et al. (2023). Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia (Nature Communications, (2023), 14, 1, (115), 10.1038/s41467-022-35624-4). (ekstern lenke)

Konferanseabstrakt

• G. Tosi; G. Forlani; Vibeke Andresen et al. (2012). Human oncogenic retrovirus HTLV-1 replication is suppressed by the MHC class II transcriptional activator CIITA via an inhibitory action on the viral transactivator Tax-1. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.